What is REACH?
Research Evaluation And Commercialization Hub (REACH) is a National Institutes of Health (NIH) program established to promote the commercialization of academic biomedical research.
REACH Hubs are a part of a group of 34 academic institutions in the NIH’s national network of proof-of-concept centers to facilitate development of best practices for bringing life science innovation to the market.
Learn more about all the NIH’s research commercialization initiatives.
What is ROI?
Rutgers Optimizes Innovation (ROI) is the name of the NIH REACH program at Rutgers University. ROI is an umbrella program designed to improve and maximize the university's total research output in the biomedical arena by providing financial as well as skills development resources and support.
ROI is funded at Rutgers University by the NIH with a $4 million award for the duration of four years with matching funds provided by the university.
What is HealthAdvance?
HealthAdvance is the application solicitation, review, award and project management platform of ROI. It is a funding mechanism to help accelerate the commercialization of promising life science technologies and/or solutions being developed by academic researchers at Rutgers.
What is the amount of a HealthAdvance grant, if awarded?
Applicant Innovators may seek up to USD200,000 in direct funds over a period of two years.
Can I apply for HealthAdvance and TechAdvance funding at the same time?
The HealthAdvance team strongly recommends that Innovators pursue only one funding type at any given time. HealthAdvance only accepts submissions pertaining to
biomedical or life science technologies that have impact on human health.
What are the submission deadlines for a HealthAdvance application?
The HealthAdvance Pre-Qualification Applications are accepted on a rolling basis all year round. An initial review of a fully complete Pre-Qualification Application is generally completed within 14 days of submission to the program.